Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.38 |
| ▸ | TGM2 | P21980 | 5/20 | 0.34 |
| ▸ | ALB | P02768 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7901824 | 0.87 | FOLH1 (0.42) | FOLH1TGM2ALBSMN1; SMN2SIRT1 | |
| SCHEMBL7908773 | 0.84 | FOLH1 (0.40) | FOLH1TGM2ALBSMN1; SMN2 | |
| SCHEMBL7915411 | 0.80 | FOLH1 (0.39) | FOLH1ALBSIRT2SIRT1MMP2 | |
| SCHEMBL7909552 | 0.78 | DPP7 (0.35) | — | |
| SCHEMBL7901699 | 0.77 | FOLH1 (0.49) | FOLH1ALBSMN1; SMN2 | |
| SCHEMBL7911894 | 0.75 | FOLH1 (0.40) | FOLH1TGM2ALBSMN1; SMN2SIRT2 | |
| SCHEMBL7911902 | 0.75 | FOLH1 (0.40) | FOLH1TGM2ALBSMN1; SMN2SIRT2 | |
| SCHEMBL8707548 | 0.74 | FOLH1 (0.40) | FOLH1TGM2SMN1; SMN2SIRT2SIRT1 | |
| SCHEMBL3438496 | 0.73 | FOLH1 (0.62) | FOLH1ALBSMN1; SMN2SIRT1 | |
| SCHEMBL7911959 | 0.70 | FOLH1 (0.48) | FOLH1ALBSMN1; SMN2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207708-B1 | FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, | G. D. SEARLE & COMPANY | 2001-03-27 | — | — | US | disclosed |
| EP-0885188-B1 | HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | SEARLE & CO (US) | 2000-09-27 | — | — | EP | disclosed |